penicillamine has been researched along with Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia in 1 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaşifoğlu, T | 1 |
| Korkmaz, C | 1 |
| Yaşar, S | 1 |
| Gülbaş, Z | 1 |
1 other study available for penicillamine and Calcinosis-Raynaud Phenomenon-Sclerodactyly-Telangiectasia
| Article | Year |
|---|---|
Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases?
Topics: Antirheumatic Agents; CREST Syndrome; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positi | 2006 |